Article Details
Retrieved on: 2024-04-17 16:35:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Obinutuzumab is an FDA-approved monoclonal antibody that kills CLL cells by binding to the CD20 protein on the cell's surface, signaling the ...
Article found on: healthtree.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here